Cancer clinical trials in the region Occitanie
205 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Lymphoma
#NCT06271057
B cell lymphoma
Large B cell lymphoma
Primary mediastinal lymphoma
Indolent transformed lymphoma
> 60 ml/min
2
3 or more
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier)
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2
Liver and bile duct cancer
#NCT05622071
Hepatocellular carcinoma
Unhealthy
B
B
C
Transplant
Immunotherapy
Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier)
UNICANCER
Phase 2
Lymphoma
#NCT05283720
B cell lymphoma
Mantel cell lymphoma
CD20
None
1
2
3 or more
Bispecific T-cell engager antibodies
IUCT Oncopôle (Toulouse)
Abbvie
Phase 2
Lymphoma
#NCT05283720
B cell lymphoma
Follicular lymphoma
CD20
1
2
3 or more
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
IUCT Oncopôle (Toulouse)
Abbvie
Phase 2
Lymphoma
#NCT05283720
B cell lymphoma
Large B cell lymphoma
Indolent transformed lymphoma
CD20
None
1
2
3 or more
Bispecific T-cell engager antibodies
IUCT Oncopôle (Toulouse)
Abbvie
Phase 2
Lymphoma
#NCT03930953
B cell lymphoma
2
3 or more
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier)
Celgene
Phase 2
Lymphoma
#NCT04802590
B cell lymphoma
Mantel cell lymphoma
None
CD20
> 60 ml/min
50-60 ml/min
None
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier)
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2
Breast cancer
#NCT05386108
HER2 Negative
HR Positive
Metastatic
Chemotherapy
Hormone therapy
Targeted therapy
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Centre de Cancérologie du Grand Montpellier (Montpellier)
Stemline Therapeutics, Inc.
Phase 2
Breast cancer
#NCT04666961
HR Positive
Localized
Systemic Treatment-Naive
BRCA 1/2
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut de Cancérologie de l'Ouest
Phase 1 / Phase 2
Colon cancer
Rectal cancer
Anal cancer
Pancreas cancer
#NCT06162221
Locally Advanced
Metastatic
KRAS G12C
Systemic Treatment-Naive
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse)
Revolution Medicines, Inc.